Patent ID: 8431702

Claim:
A method of facilitating ocular wound healing in a mammal, or of treating a disease or condition selected from macular degeneration, retinal edema, retinal degeneration, idiopathic pulmonary fibrosis, diabetic retinopathy, optic neuropathy, and glaucomatous retinopathy in a mammal in need of such treatment, comprising administering to said mammal a pharmaceutical composition comprising a substituted hydropyrido-quinoline represented by the structural formula: wherein: Y is C or N; X is oxygen, sulfur or NR N ; R N is H or C 1-6 alkyl; B is C 1-6 alkyl, C 1-6 alkenyl or C 1-6 alkyl having at least one halo atom of F, Cl, Br, or I as substituent; R 3 is hydrogen or C 1-6 alkyl; each R 1 is independently hydrogen or C 1-6 alkyl; each R 2 is independently substituted or unsubstituted phenyl; in combination with at least one additional component selected from the group consisting of one or more emulsifying agent, wetting agent, sweetening agent, flavoring agent, tonicity adjuster, preservative, buffer, anti-oxidant and combinations thereof.